The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Myasthenia Gravis Treatment Global Market Report 2023, the myasthenia gravis treatment market is expected to show significant growth in the forecast period.

Key insights from the myasthenia gravis treatment market forecast include:

1. Market Size

The worldwide myasthenia gravis treatment market is anticipated to increase from $1.31 billion in 2022 to $1.42 billion in 2023, with a CAGR of 8.46%. The market size is projected to reach $1.90 billion in 2027, growing at a CAGR of 7.50%.

2. Major Driver

The rise in myasthenia gravis prevalence is poised to drive the myasthenia gravis treatment market’s expansion. In January 2022, the National Organization for Rare Disorders, a US-based non-profit supporting those with rare diseases, reported an estimated prevalence of 14–40 per 100,000 individuals in the United States. A study by Iran’s Kermanshah University of Medical Sciences and University Putra Malaysia in December 2021 estimated the global prevalence at 12.4 people per 100,000. As a result, the increasing myasthenia gravis prevalence fuels the growth of the myasthenia gravis treatment market.

View More On The Myasthenia Gravis Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/myasthenia-gravis-treatment-global-market-report

3. Key Trend

Innovative product development is a prominent trend in the myasthenia gravis treatment market. Leading companies in the myasthenia gravis treatment sector focus on creating new solutions to strengthen their market standing. For instance, in December 2021, the Netherlands-based biopharmaceutical firm, Argenx SE, gained FDA approval for VYVGARTô, a novel drug for treating generalized myasthenia gravis in adult patients with anti-acetylcholine receptor (AChR) antibodies. VYVGARTô is the first FDA-approved neonatal Fc receptor (FcRn) blocker for myasthenia gravis treatment, and the company has collaborated with various commercial payers to establish a value-based agreement, ensuring patient access and cost predictability for payers.

4. Largest Region

North America was the largest region in the myasthenia gravis treatment market in 2022.

5. Major Players

Major players in the myasthenia gravis treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Baxter International Inc., Biogen Idec, Astellas Pharma Inc., CSL Limited, Chugai Pharmaceutical Co. Ltd., Grifols S.A, UCB Inc., Mitsubishi Tanabe Pharma Corp., Genentech Inc., Horizon Therapeutics plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Kedrion SpA, CuraVac Inc., AryoGen Pharmed, RemeGen Co. Ltd., Kashiv BioSciences LLC, Avadel Pharmaceuticals plc, Immunovant Inc., Cabaletta Bio Inc., Argenx SE, NMD Pharma A/S, Cartesian Therapeutics Inc., DAS Therapeutics Inc., Harbour BioMed Holdings Ltd., Zenyaku Kogyo Co. Ltd., AnTolRx Inc., CytoDyn Inc., and Ahead Therapeutics.

Request A Sample Of The Global Myasthenia Gravis Treatment Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=11980&type=smp

Key Myasthenia Gravis Treatment Market Segments

The global myasthenia gravis treatment market is segmented –

1) By Treatment: Medication, Surgery, Other Treatments
2) By Medication Type: Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, Other Medication Types
3) By End-Use: Hospitals, Clinics, Other End-Uses

The Myasthenia Gravis Treatment Global Market Report 2023  provides an in-depth analysis on the myasthenia gravis treatment market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the myasthenia gravis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. 

View More Related Reports –
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Wastewater Treatment Equipment Global Market Report 2023
Polycystic Ovarian Syndrome Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model